Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...
Abstract: Anaglyph image separation recovering a stereo image pair from an anaglyph image is a classical and ill-posed image recovery problem. We observed that there is always an interpenetration ...
Abstract: This paper presents a scene agnostic neural architecture for camera localization, where model parameters and scenes are independent from each other.Despite recent advancement in learning ...
The median overall survival was 50.5 months among patients who received surufatinib at any time and 22.8 months in patients who never received surufatinib. Surufatinib did not provide an overall ...
The Executive Director in the Ministry of Education, Arts and Culture, Sanet Steenkamp has criticized school principals for sending learners away for not being able to afford school fees. She said ...
kykNET announced the cast of its new telenovela Diepe Waters. The show centres on the Swarts family and their business, the Swartmarlyne swimming club. Cast members include Justin Strydom, Sandi ...
Lung cancer is the most common cause of cancer death worldwide. A timely diagnosis of the pulmonary nodules makes it possible to detect lung cancer in the early stage, and thoracic computed tomography ...
The safety and efficacy of PEN-221 somatostatin analog (SSA)-DM1 conjugate in patients (PTS) with advanced GI mid-gut neuroendocrine tumor (NET): Phase 2 results. This is an ASCO Meeting Abstract from ...
A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO). Background: Surufatinib (S) is an inhibitor of VEGFR1, 2, & 3; FGFR1; and CSF-1R. In two phase ...
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results